JP2015504066A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015504066A5 JP2015504066A5 JP2014550770A JP2014550770A JP2015504066A5 JP 2015504066 A5 JP2015504066 A5 JP 2015504066A5 JP 2014550770 A JP2014550770 A JP 2014550770A JP 2014550770 A JP2014550770 A JP 2014550770A JP 2015504066 A5 JP2015504066 A5 JP 2015504066A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- pharmaceutical composition
- composition according
- pathological condition
- metal complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261583377P | 2012-01-05 | 2012-01-05 | |
| US61/583,377 | 2012-01-05 | ||
| US201261656178P | 2012-06-06 | 2012-06-06 | |
| US61/656,178 | 2012-06-06 | ||
| US201261668679P | 2012-07-06 | 2012-07-06 | |
| US61/668,679 | 2012-07-06 | ||
| US201261721575P | 2012-11-02 | 2012-11-02 | |
| US61/721,575 | 2012-11-02 | ||
| PCT/IB2012/056959 WO2013102806A1 (en) | 2012-01-05 | 2012-12-04 | Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017081176A Division JP6316479B2 (ja) | 2012-01-05 | 2017-04-17 | カルマンガホジピル、新たな化学実体、および他の混合金属錯体、調製の方法、組成物、および処置の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015504066A JP2015504066A (ja) | 2015-02-05 |
| JP2015504066A5 true JP2015504066A5 (https=) | 2016-01-28 |
| JP6131271B2 JP6131271B2 (ja) | 2017-05-17 |
Family
ID=47559596
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014550770A Active JP6131271B2 (ja) | 2012-01-05 | 2012-12-04 | カルマンガホジピル、新たな化学実体、および他の混合金属錯体、調製の方法、組成物、および処置の方法 |
| JP2017081176A Active JP6316479B2 (ja) | 2012-01-05 | 2017-04-17 | カルマンガホジピル、新たな化学実体、および他の混合金属錯体、調製の方法、組成物、および処置の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017081176A Active JP6316479B2 (ja) | 2012-01-05 | 2017-04-17 | カルマンガホジピル、新たな化学実体、および他の混合金属錯体、調製の方法、組成物、および処置の方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US9187509B2 (https=) |
| EP (1) | EP2800755B1 (https=) |
| JP (2) | JP6131271B2 (https=) |
| KR (1) | KR102086022B1 (https=) |
| CN (2) | CN107353313B (https=) |
| AU (1) | AU2012364227B2 (https=) |
| BR (1) | BR112014016497B1 (https=) |
| CA (1) | CA2862736C (https=) |
| ES (1) | ES2683038T3 (https=) |
| HK (1) | HK1245276B (https=) |
| IN (1) | IN2014MN01495A (https=) |
| MX (1) | MX2014008247A (https=) |
| RU (2) | RU2765805C2 (https=) |
| WO (1) | WO2013102806A1 (https=) |
| ZA (1) | ZA201404904B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107353313B (zh) | 2012-01-05 | 2019-04-09 | 普莱制药公司 | 新化学实体钙锰福地吡和其他混合金属配合物、制备方法、组合物以及治疗方法 |
| MX376321B (es) * | 2012-11-02 | 2025-03-07 | Egetis Therapeutics Ab | Usos para el tratamiento de cancer. |
| US10233205B2 (en) | 2015-08-07 | 2019-03-19 | Auburn University | Magnetic resonance imaging contrast agent capable of detecting hydrogen peroxide and reducing reactive oxygen species |
| EP3842040B1 (en) | 2016-01-11 | 2022-03-09 | Egetis Therapeutics AB | Methods and formulations for treatment of and/or protection against acute liver failure and other hepatotoxic conditions |
| KR20190085967A (ko) | 2016-11-14 | 2019-07-19 | 칼슨-튜너 인베스트 에이에스 | 화학요법으로-유도된 psn을 예방 및 치료하기 위한 비-전이 금속 배위된 디피리독실 화합물의 용도 |
| WO2022244757A1 (ja) | 2021-05-18 | 2022-11-24 | 株式会社Ｌｔｔバイオファーマ | 抗癌剤の投与に伴う障害を治療又は予防するための医薬組成物 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5091169A (en) | 1987-05-08 | 1992-02-25 | Salutar, Inc. | Dipyridoxyl phosphate NMRI contrast agent compositions |
| AR246956A1 (es) * | 1987-05-08 | 1994-10-31 | Salutar Inc | Compuesto quelante, un intermediario para preparar el mismo, y un procedimiento para preparar una composicion de medio de contraste. |
| US5223243A (en) | 1987-05-08 | 1993-06-29 | Salutar, Inc. | Dipyridoxyl phosphate chelating compound intermediates useful as NMRI contrast agents |
| US5403834A (en) * | 1992-12-07 | 1995-04-04 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| US6204259B1 (en) | 1993-01-14 | 2001-03-20 | Monsanto Company | Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| GB9613182D0 (en) | 1996-06-24 | 1996-08-28 | Nycomed Imaging As | Method |
| GB9727224D0 (en) | 1997-12-23 | 1998-02-25 | Nycomed Imaging As | Method |
| AU1770299A (en) * | 1997-12-23 | 1999-07-19 | Nycomed Imaging As | Nitric oxide releasing chelating agents and their therapeutic use |
| FR2823977B1 (fr) | 2001-04-26 | 2006-12-01 | Univ Rene Descartes | Utilisation du mangafodipir dans le traitement des effets d'un stress oxydatif |
| DE10359628A1 (de) | 2003-12-18 | 2005-07-21 | Oxeno Olefinchemie Gmbh | Katalysator und Verfahren zur Herstellung von 1-Olefinen aus 2-Hydroxyalkanen |
| US20070148154A1 (en) | 2004-12-17 | 2007-06-28 | Universite Rene Descartes (Paris V) | Use of superoxide dismutase mimetics and reductase gultatione in the form of anticancer drugs |
| KR101678865B1 (ko) * | 2007-12-14 | 2016-11-23 | 플레드파르마 에이비 | 암의 치료에 사용하기 위한 화합물들 |
| US8414866B2 (en) * | 2007-12-17 | 2013-04-09 | Ge Healthcare As | Method of magnetic resonance imaging of the heart with paramagnetic MN2+ |
| CN105688215A (zh) | 2009-07-06 | 2016-06-22 | 普莱制药公司 | 利用锰配合物化合物与所述化合物之非锰配合物形式的组合的药物组合物和治疗方法 |
| CN107353313B (zh) * | 2012-01-05 | 2019-04-09 | 普莱制药公司 | 新化学实体钙锰福地吡和其他混合金属配合物、制备方法、组合物以及治疗方法 |
-
2012
- 2012-12-04 CN CN201710588057.1A patent/CN107353313B/zh active Active
- 2012-12-04 JP JP2014550770A patent/JP6131271B2/ja active Active
- 2012-12-04 IN IN1495MUN2014 patent/IN2014MN01495A/en unknown
- 2012-12-04 ES ES12815799.7T patent/ES2683038T3/es active Active
- 2012-12-04 KR KR1020147021727A patent/KR102086022B1/ko not_active Expired - Fee Related
- 2012-12-04 CN CN201280070691.1A patent/CN104169291B/zh active Active
- 2012-12-04 WO PCT/IB2012/056959 patent/WO2013102806A1/en not_active Ceased
- 2012-12-04 US US14/369,153 patent/US9187509B2/en active Active
- 2012-12-04 BR BR112014016497-5A patent/BR112014016497B1/pt active IP Right Grant
- 2012-12-04 RU RU2017119660A patent/RU2765805C2/ru active
- 2012-12-04 CA CA2862736A patent/CA2862736C/en active Active
- 2012-12-04 RU RU2014132184A patent/RU2622646C2/ru active
- 2012-12-04 MX MX2014008247A patent/MX2014008247A/es active IP Right Grant
- 2012-12-04 EP EP12815799.7A patent/EP2800755B1/en active Active
- 2012-12-04 AU AU2012364227A patent/AU2012364227B2/en active Active
-
2014
- 2014-07-02 ZA ZA2014/04904A patent/ZA201404904B/en unknown
-
2015
- 2015-10-26 US US14/922,555 patent/US9597334B2/en active Active
-
2017
- 2017-02-28 US US15/445,588 patent/US10111893B2/en active Active
- 2017-04-17 JP JP2017081176A patent/JP6316479B2/ja active Active
-
2018
- 2018-04-04 HK HK18104469.4A patent/HK1245276B/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015504066A5 (https=) | ||
| US6391895B1 (en) | Nitric oxide releasing chelating agents and their therapeutic use | |
| RU2014132184A (ru) | Калмангафодипир, новое химическое соединение и другие смешанные комплексные соединения с металлами, способы получения, композиции и способы лечения | |
| US20160271116A1 (en) | Polyethylene glycol-cactus oligopeptide bonding rapamycin derivatives | |
| US8809562B2 (en) | Use of metallocene compounds for cancer treatment | |
| HK1245276A1 (en) | Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment | |
| RU2012103889A (ru) | Фармацевтические композиции и терапевтические способы, в которых применяется комбинация комплексного соединения марганца и соединения в форме, не являющейся марганцевым комплексом | |
| US20240100066A1 (en) | ORAL Pt (IV) ANTICANCER PRODRUG CONTAINING 3-BROMOPYRUVATE AS AXIAL LIGAND | |
| CN105396142B (zh) | 人血清白蛋白‑药物复合物及其合成方法和应用 | |
| KR101678865B1 (ko) | 암의 치료에 사용하기 위한 화합물들 | |
| CN110305166B (zh) | 一种以姜黄素衍生物为配体的钌(ii)配合物及其制备方法和应用 | |
| Barbara et al. | In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma | |
| WO2011008132A1 (ru) | Низкомолекулярные модуляторы фармакологической активности | |
| JP6021847B2 (ja) | 扁平上皮ガン及び肝ガンの抑制剤とされるスチルベノイド化合物及びその用途 | |
| US20150313921A1 (en) | Cancer Treatment Methods | |
| CN102746316A (zh) | 用于抗肿瘤药物的间硝基芳甲氧基喜树碱缺氧激活前药 | |
| Hasan | Copper (II) Complexes as Potential Anti-Cancer Agents Compared to Cisplatin | |
| CN110139673B (zh) | 使用非过渡金属配位的二吡哆基化合物以预防和治疗化疗诱发的psn | |
| HK1151971B (en) | Compounds for use in the treatment of cancer | |
| EP3655414A1 (en) | Deferoxamine derivatives as medicaments | |
| HK1203203B (en) | Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment |